echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > J Gastroenterology: CCL19 can enhance CD8+ T cell response and accelerate HBV clearance

    J Gastroenterology: CCL19 can enhance CD8+ T cell response and accelerate HBV clearance

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    About 250 million people worldwide are infected with hepatitis B virus (HBV) and are in various stages of liver degeneration, such as hepatic steatosis, cirrhosis, end-stage liver failure or hepatocellular carcinoma


     


     


    + + + + + + +

     

    The results of this study provide new insights into how the CCL19/CCR7 axis regulates the host immune system.


    The results of this study provide new insights into how the CCL19/CCR7 axis regulates the host immune system.


     

    Original source:

    Yan Yan.


    CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.